The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 902-907

  Malone, John I ^a,b   Lowitt, Saul ^a   Salem, Angela F ^a   Miranda, Candy ^a   Korthals, Jan K ^a   Carver, Jane ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; ALDOSE REDUCTASE INHIBITOR; FATTY ACID; HEMOGLOBIN A1C; INSULIN ZINC SUSPENSION; SORBINIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFECT; FATTY ACID METABOLISM; HYPERGLYCEMIA; MALE; MYELINATED NERVE; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029936915     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90167-5     Document Type: Article

References (25)

1. Eliasson SG: Nerve conduction changes in experimental diabetes. J Clin Invest 43:2353-2358, 1964
2. Greene DA, Lattimer SA: Action of sorbinil in diabetic peripheral nerve: Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes 33:712-716, 1984
3. Sima AAF, Prashar A, Zhang W-X, et al: Preventive effect of long-term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest 85:1410-1420, 1990
4. Brismar T, Sima AAF, Green DA: Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 21:504-507, 1987
5. Thomas PK, Fraher JP, O'Leary D, et al: Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat (effect of streptozotocin-induced diabetes). Acta Neuropathol 79:375-386, 1990
6. Gillon KRW, Hawthorne JN, Tomlinson DR: Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition. Diabetologia 25:365-371, 1983
7. Malone JI, Harvey RC, Benford S, et al: Taurine deficiency may cause nerve dysfunction in streptozotocin diabetic rats. Diabetes Res Clin Pract 1:S356, 1985 (suppl 1, abstr)
8. Sima AAF, Bril V, Nathaniel V, et al: Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 319:548-555, 1988
9. Holman RT, Johnson SB, Gerrard JM, et al: Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci USA 80:2375-2379, 1983
10. Tilvia RS, Miettinen TA: Fatty acid composition of serum lipids, erythrocytes and platelets in insulin-dependent diabetic women. J Clin Endocrinol Metab 61:741-745, 1985
11. Dang AQ, Faas FH, Lee JA, et al: Altered fatty acid composition in the plasma, platelets and aorta of the streptozotocin-induced diabetic rat. Metabolism 37:1063-1072, 1988
12. Zhu X, Eichberg J: 1,2-Diacylglycerol content and its archidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 53:1087-1090, 1990
13. Cameron NE, Cotter MA, Robertson S: Essential fatty acid diet supplementation. Effect on peripheral nerve and skeletal muscle function and capillarization in streptozotocin-induced diabetic rats. Diabetes 40:532-539, 1991
14. Fernandez E, Pallini R, Gangitano C, et al: Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: Effects of acetyl-L-carnitine. Int J Clin Pharmacol Res 10:85-99, 1990
15. Malone JI, Lowitt S, Corsico N, et al: Altered neuroexcitability in experimental diabetic neuropathy: Effect of acetyl-L-carnitine. Int J Clin Pharmacol Res 12:237-241, 1992
16. Lowitt S, Malone JI, Salem AF, et al: Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 44:677-680, 1995
17. Folch J, Lees M, Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
18. Morrison WR, Smith LM: Preparation of fatty acid methyl esters and dimethylacetals. J Lipid Res 5:600-608, 1964
19. Dyck PJ, Giannini C, Lais A: Pathological alterations of nerves, in Dyck PJ, Thomas PK, Griffin JW, et al: (eds): Peripheral Neuropathy. Philadelphia, PA, Saunders, 1993, pp 514-595
20. Yagikashis S, Kamijo M, Ido Y, et al: Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozotocin-induced diabetes rats. Diabetes 39:690-696, 1990
21. Jirmanova I: Giant axonopathy in streptozotocin diabetes of rats. Acta Neuropathol 86:42-48, 1993
22. Fraher JP, O'Leary D, Moran MA, et al: Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat (normal animals). Acta Neuropathol 79:364-374, 1990
23. Dyck PJ, Lambert EH, Windebank AJ, et al: Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 71:507-514, 1981
24. Ido Y, McHowat J, Chang KC, et al: Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes 43:1469-1477, 1994
25. Malone JI, Leavengood H, Peterson MJ, et al: Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes 33:45-49, 1984